<DOC>
	<DOCNO>NCT02173184</DOCNO>
	<brief_summary>To investigate efficacy ( therapeutic response ) Gynevac vaccination follow 5-shot treatment period patient bacterial vaginosis , base Nugent Score Amsel criterion</brief_summary>
	<brief_title>Safety Efficacy Study Gynevac Lactobacillus Vaccine Treatment Bacterial Vaginosis</brief_title>
	<detailed_description />
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adult premenopausal female , 18 year old . Mentally competent patient comply study protocol able complete keep study relate material ( patient diary , etc. ) . Signed date write informed consent . Clinical diagnosis BV accord Amsel criterion Gram stain Nugent Score â‰¥7 Nugent Score 46 presence clue cell Patient need antiinfective treatment would require specific treatment vaginosis prevent development acute vaginitis may affect treatment outcome BV . Negative pregnancy test screening . Patients infectious cause vulvovaginitis ( e.g . Vaginal candidiasis , Trichomonas vaginalis ) . Patients another vaginal vulvar condition , would confound interpretation clinical therapeutic response . Patients receive antifungal antimicrobial therapy ( systemic intravaginal ) , part standard clinical practice , clinical trial , within 14 day randomization . Patients diagnose chronic inflammatory disease ( Rheumatoid Arthritis , psoriasis , Crohn 's disease , Coeliac disease , spondyloarthritis rheumatica etc . ) Women schedule treatment study period cervical intraepithelial neoplasia ( CIN ) cervical carcinoma . Pregnancy lactation . Patients know hypersensitivity formaldehyde . Patients undergoing antibiotic treatment . Patients acute polyarthritis , know serious cardiac , liver , kidney disease unstable diabetes mellitus . Known abnormality blood circulation haemopoietic system . Use investigational drug within 30 day randomization . Patients abstain use intravaginal product least 7 day prior study randomization ( e.g . douche , female deodorant spray , spermicide , condom , tampon , diaphragm ) . Patients also refrain use intravaginal product 3 day prior study visit . Patients abstain vaginal intercourse least 3 day prior study visit .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>bacterial vaginosis</keyword>
	<keyword>Gynevac Lactobacillus vaccine</keyword>
</DOC>